Next Article in Journal
Using Cholinesterases and Immobilized Luminescent Photobacteria for the Express-Analysis of Mycotoxins and Estimating the Efficiency of Their Enzymatic Hydrolysis
Next Article in Special Issue
Electric Blue: Molecular Evolution of Three-Finger Toxins in the Long-Glanded Coral Snake Species Calliophis bivirgatus
Previous Article in Journal
A Monoclonal Antibody Combination against both Serotypes A and B Botulinum Toxin Prevents Inhalational Botulism in a Guinea Pig Model
Previous Article in Special Issue
Toxicological Characterization and Phospholipase D Activity of the Venom of the Spider Sicarius thomisoides
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

BmK NSPK, a Potent Potassium Channel Inhibitor from Scorpion Buthus martensii Karsch, Promotes Neurite Outgrowth via NGF/TrkA Signaling Pathway

Department of TCM Pharmacology, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Toxins 2021, 13(1), 33; https://doi.org/10.3390/toxins13010033
Submission received: 3 December 2020 / Revised: 30 December 2020 / Accepted: 31 December 2020 / Published: 5 January 2021
(This article belongs to the Special Issue Animal Venoms and Their Components: Molecular Mechanisms of Action)

Abstract

:
Scorpion toxins represent a variety of tools to explore molecular mechanisms and cellular signaling pathways of many biological functions. These toxins are also promising lead compounds for developing treatments for many neurological diseases. In the current study, we purified a new scorpion toxin designated as BmK NSPK (Buthus martensii Karsch neurite-stimulating peptide targeting Kv channels) from the BmK venom. The primary structure was determined using Edman degradation. BmK NSPK directly inhibited outward K+ current without affecting sodium channel activities, depolarized membrane, and increased spontaneous calcium oscillation in spinal cord neurons (SCNs) at low nanomolar concentrations. BmK NSPK produced a nonmonotonic increase on the neurite extension that peaked at ~10 nM. Mechanistic studies demonstrated that BmK NSPK increased the release of nerve growth factor (NGF). The tyrosine kinases A (TrkA) receptor inhibitor, GW 441756, eliminated the BmK NSPK-induced neurite outgrowth. BmK NSPK also increased phosphorylation levels of protein kinase B (Akt) that is the downstream regulator of TrkA receptors. These data demonstrate that BmK NSPK is a new voltage-gated potassium (Kv) channel inhibitor that augments neurite extension via NGF/TrkA signaling pathway. Kv channels may represent molecular targets to modulate SCN development and regeneration and to develop the treatments for spinal cord injury.
Key Contribution: BmK NSPK, a new potent potassium channel blocker was purified from Buthus martensii Karsch, which augmented spontaneous calcium oscillations in spinal cord neurons (SCNs) and produced a nonmonotonic increase in the neurite outgrowth in SCNs. BmK NSPK-augmented neurite extension was through NGF/TrkA receptor signaling pathway.

Graphical Abstract

1. Introduction

Scorpion venoms are the biological weapon for scorpion to capture their prey and defend against their predators. Scorpion intoxication has been frequently reported worldwide, especially in Israel [1] and the United States of America [2]. The Chinese scorpion, Buthus martensii Karsch (BmK), is less toxic. However, as a Chinese traditional medicine, BmK has been widely used for thousands of years to treat facial palsy [3], epilepsy [4], stroke [5], and pain [6] in the clinical practice. Scorpion venoms contain hundreds of structurally diverse peptides with distinct biological activities. These peptides can modulate the activities of many plasma-membrane-tethered channels/receptors and the proteins expressed in the endoplasmic reticulum, often with high affinity and high selectivity [7]. Ion channels are the main targets of scorpion toxins. Studies have demonstrated that scorpion toxins can modulate the gating kinetics of many ion channels, including voltage-gated potassium channels (Kv channels) [8], voltage-gated sodium channels (VGSCs) [7,9], voltage-gated calcium channels (Cav channels) [10], chloride channels [11], and ryanodine receptors [12]. Due to their high affinity and selectivity, scorpion toxins are widely used as tools to explore the gating mechanism of ion channels [13] and their downstream cellular signaling pathways [14]. Typically, long-chain scorpion toxins (60–74 amino acid residues) bind to VGSCs, whereas the short-chain scorpion toxins (30–40 amino acid residues) modify Kv channel activity. All scorpion Kv channel inhibitors form a common cysteine-stabilized α-helix-β-sheet (Csαβ) motif [15].
Activity-dependent neurite outgrowth is a critical step to the proper neuronal network formation both in developing nerve system and during nerve regeneration [16]. Ca2+ signaling plays key roles in activity-dependent dendritic arborization, axonal elongation, and synapse formation [17]. Modulation of ion channel activity can directly or indirectly affect the Ca2+ signaling. For example, both VGSC channel gating modifiers and Kv channel blockers have been reported to alter the fidelity of the Ca2+ signaling and modulate the neurite outgrowth in cortical neurons [18,19]. Recently, several long-chain scorpion toxins were reported to display neurotropic effect both in in vivo model [20] and in primary cultured neurons [7,21] by increasing brain-derived neurotrophic factor (BDNF) expression and phosphorylation levels of cyclic adenosine monophosphate (cAMP)-response element binding (CREB) and extracellular-regulated protein kinases 1/2 (ERK1/2) proteins.
In the present study, we aimed to discover new scorpion peptide that can modify neuronal Ca2+ dynamics and to explore its potential in the stimulation of neurite outgrowth. We purified a new scorpion peptide designated to be BmK neurite-stimulating peptide targeting Kv channels (NSPK) from BmK venom. BmK NSPK potently increased spontaneous calcium oscillation (SCO) frequency and amplitude and inhibited outward potassium channel current without affecting the VGSC channel activity in spinal cord neurons (SCNs). BmK NSPK stimulated neurite outgrowth, increased the release of nerve growth factor (NGF) and the phosphorylation levels of protein kinase B (Akt) that is downstream signaling molecules of tyrosine kinases A (TrkA) receptors. Furthermore, TrkA receptor inhibitor, GW 441756 (GW), eliminated the BmK NSPK-induced neurite outgrowth, demonstrating that BmK NSPK, a new Kv inhibitor, enhanced neurite outgrowth through NGF/TrkA signaling pathway.

2. Results

2.1. BmK NSPK Purification and Structure Determination

Scorpion toxins have been demonstrated to regulate the activities of a variety of ion channels by modulating their gating kinetics and therefore modulating neuronal activity [7,9,18,21]. We therefore further analyzed BmK venom components to discover new scorpion peptide that can modify neuronal Ca2+ dynamics and to explore its potential in the stimulation of neurite outgrowth, a critical step for the nerve development and nerve regeneration [22]. After size-exclusive ion-exchange and RP-HPLC chromatography, a single peak at retention time of 16.95 min designated to be BmK NSPK was collected (Figure 1A). The unitality of the peptide was accessed by RP-HPLC (Figure 1B). ESI-MS gave the multiple ion charges of 1321.7, 991.6, and 793.5 m/z that corresponded to [M+3H]3+, [M+4H]4+, and [M+5H]5+, respectively, demonstrating that the molecular weight of BmK NSPK was 3962.3 Da, which is distinct from the molecular weights of currently reported BmK toxins (Figure 1C).
The primary amino acid sequence of BmK NSPK was determined to be VGKNVICIHSGQCLIPCIDAGMRFGICKNGICDCTPKG (Figure 2A) using Edman degradation with theoretic molecular weight (MW) of 3962.9 Da that is consistent with the molecular weight determined by ESI-MS. Analysis using Clustal X software showed that BmK NSPK displayed over 70% sequence homology to current known Kv channel blockers such as Buthus martensii Kaliotoxin (BmKTX) [23], Kaliotoxin 2 (KTX-2) [24], Mesobuthus eupeus potassium channel toxin (MeuKTx) [25], and Mesobuthus eupeus potassium channel toxin 13-3 (MeKTx13-3) [26] (Figure 2A). Homology modeling using BmKTX as a template [23] demonstrated that BmK NSPK belonged to classical Csαβ potassium channel blockers from scorpion venom [27] that contained one α-helix and two antiparallel β-sheets (Figure 2B). The α-helix of BmK NSPK peptide comprised residues Leu14 to Asp19, which was slightly shorter than the α-helix of BmKTX (Leu14 to Ala20) [23]. However, the difference of the α-helix folding between BmK NSPK and BmKTX was marginal. The two antiparallel β-sheets of BmK NSPK were from Gly25 to Cys27 and Ile31 to Cys34, similar to that of BmKTX [23].

2.2. BmK NSPK Altered Calcium Dynamics and Depolarized Membrane in Primary Cultured SCNs

The main targets of scorpion toxins are ion channels that orchestrate Ca2+ dynamics in neurons [7,21] that define the pattern of gene expression and neuronal network formation [28]. Primary cultured SCNs display synchronized spontaneous calcium oscillations (SCOs) [7] that are balanced by excitatory and inhibitory neuronal inputs [28,29]. Alteration of the pattern of SCOs has been used to discover the neuroprotective compound for seizure [30] and pain [31], and also to discover neurotoxicants and explore their mechanisms [18,32,33]. We therefore explored the influence of BmK NSPK on SCOs in primary cultured SCNs. Addition of BmK NSPK produced a rapid and sustained increase in both the amplitude and frequency of SCOs (Figure 3A) with the concentration of toxin at half-maximal efficacy (EC50) values of 13.4 nM (4.00–45.1 nM, 95% confidence intervals, 95% CI, Hill slope = 1.0) and 6.22 nM (2.22–17.4 nM, 95% CI, Hill slope = 1.0), respectively (Figure 3B,C). Application of BmK NSPK also resulted in a concentration-dependent membrane depolarization (Figure 3D,E).

2.3. BmK NSPK Directly Inhibits Kv Channels in Spinal Cord Neurons

Short-chain scorpion toxins mainly affect Kv channel activity [24], although exceptions exist [34]. We therefore assessed BmK NSPK effect on the Kv channels in SCNs. In SCNs, outward K+ currents (IK) that contain both transient (IA) and sustained delayed-rectifier (ID) components are responsible for the repolarization of action potentials [35,36]. To examine the influence of BmK NSPK on Kv channels, the outward K+ currents (IK = IA + ID) were elicited by depolarizing potentials ranging from −60 to +80 mV (10 mV increase) from a holding potential of −110 mV (Figure 4A). Application of BmK NSPK (300 nM) inhibited the IK currents at all depolarized potentials (Figure 4A,B). The inhibitory effect of BmK NSPK on the IK currents was voltage-dependent (Figure 4B). BmK NSPK concentration-dependently suppressed the IK currents elicited by a depolarization from −110 mV to +70 mV (Figure 4C) with IC50 value of 2.42 nM (0.68–8.61 nM, 95% CI, Hill slope = −0.86) (Figure 4J). To record the ID currents, cells were pre-depolarized to a potential of −40 mV for 200 ms that inactivated IA current, before stepping to the potentials ranging from −60 to +80 mV (10 mV increment) (Figure 4D). A concentration of 300 nM of BmK NSPK inhibited ID currents elicited by a series of depolarization potentials with voltage dependence (Figure 4D,E). BmK NSPK concentration-dependently suppressed the ID currents elicited by a depolarization from a holding potential of −40 mV to +70 mV (Figure 4F) with an IC50 value of 2.24 nM (0.68–7.44 nM, 95% CI, Hill slope = −0.86) (Figure 4J). To measure the IA currents, ID currents were subtracted from the total of the outward IK currents at each respective depolarizing potential. BmK NSPK (300 nM) suppressed IA currents at each depolarizing potential (Figure 4G,H). BmK NSPK concentration-dependently suppressed the IA currents (Figure 4I) with an IC50 value of 0.93 nM (0.41–2.13 nM, 95% CI, Hill slope = −1.27) (Figure 4J). In contrast to Kv channels, BmK NSPK (1000 nM) had no effect on the Na+ currents elicited by depolarizing steps from a holding potential of −100 mV to +45 mV in a 5 mV increment, whereas tetrodotoxin (TTX, 3 nM) suppressed the Na+ currents (Figure 4K). The maximal inhibition by BmK NSPK of ID currents was ~43%, whereas the maximal inhibition by BmK NSPK of IA currents was much greater, reaching ~75% (Figure 4J).

2.4. BmK NSPK Enhances Neurite Outgrowth in Cultured SCNs

Small molecules inhibiting Kv channels are reported to augment SCOs and stimulate neurite outgrowth [18,37]. We therefore examined the ability of BmK NSPK to stimulate neurite outgrowth in SCNs. Application of BmK NSPK for 48 h commencing 5 h post-plating stimulated neurite extension in cultured SCNs in a nonmonotonic manner, with maximal stimulation occuring at the concentration around 10 nM (Figure 5A,B).

2.5. BmK NSPK-Induced Neurite Outgrowth is Dependent on NGF/TrkA Signaling Pathway

NGF has been reported to enhance the neurite extension in rat adrenal pheochromocytoma (PC12) cells [38] and sensory neurons [39] via TrkA receptors. We therefore examined whether BmK NSPK can modulate the release of NGF in SCNs. Application of BmK NSPK (10 nM) produced a significant release (~50%) of NGF that lasted for at least 8 h (Figure 6A). To examine whether BmK NSPK-induced neurite outgrowth was though TrkA receptors, a specific TrkA receptor inhibitor, GW 441756 (GW), was added 30 min before BmK NSPK exposure. GW (1 μM) abolished BmK NSPK-induced neurite outgrowth (Figure 6B,C), suggesting that BmK NSPK promoted neurite outgrowth through NGF-induced TrkA signaling pathway.
NGF binding to TrkA receptors can activate downstream regulators such as Akt, which have been reported to contribute to neuronal differentiation and dendritic arborization [40,41]. We therefore examined whether Akt was activated after BmK NSPK exposure. BmK NSPK (30 nM) rapidly increased phosphorylated levels of Akt as early as 5 min after exposure, and this effect lasted at least for 30 min (Figure 7).

3. Discussions

Scorpion toxins are invaluable tools to explore the gating mechanism of many ion channels as well as the downstream cellular signaling pathways due to their high affinity and selectivity [42,43]. These toxins are also lead compounds in the development of treatments for many neurological diseases, such as pain [6]. In the current study, we purified a new short-chain scorpion peptide designated to be BmK NSPK. Structurally, BmK NSPK displayed over 70% sequence homology to current known Kv channel blockers such as BmKTX [23], KTX-2 [24], MeuKTx [25], and MeKTx13-3 [26]. However, difference in the primary sequence was significant between BmK NSPK and BmKTX. BmK NSPK contained many isoleucine residues (Ile6, Ile8, Ile15, Ile18, Ile26, and Ile31) that in BmKTX, KTX-2, MeuKTx, and MeKTx13-3 were conserved to be a lysine. Homology modeling using BmKTX as a template [23] demonstrated that BmK NSPK contained a short α-helix (Leu14–Asp19) connected by a tight turn to a two-stranded antiparallel β-sheet (Gly25–Cys27 and Ile31–Cys34), suggesting that BmK NSPK contained a classical Csαβ motif, a conserved three-dimensional structure of Kv channel blockers from different species of scorpion venoms [27].
Pharmacologically, BmK NSPK suppressed outward potassium channel currents with potency at single-digit nanomolar concentrations. It should be mentioned that although the relative potencies of BmK NSPK on the suppression of IA and ID currents were similar, the maximal inhibition of BmK NSPK on IA currents was much greater than that on ID currents, suggesting that transient Kv channels were likely more susceptible to BmK NSPK exposure. However, inhibition of IK, IA, and ID currents by BmK NSPK were incomplete even at the highest concentration (100 nM). This is likely because some subtypes of ID and IA channels are not sensitive to BmK NSPK. The selectivity of BmK NSPK on subtype of Kv channels needs further exploration. BmK NSPK displayed similar potency to highly homologous scorpion toxins such as BmKTX [44], MeuKTX [25], and MeKTx13-2 [26], which suppressed Kv channels with potencies from high picomolar to low nanomolar concentrations. The amino acids of Arg23, Lys26, and Asn29 have been reported to be the key residues for BmKTX to suppress Kv channels [23]. Although amino acid residues (Arg23 and Asn29) were conserved between BmK NSPK and BmKTX, the residue (Lys26) in BmKTX was mutated to be an Ile26 in BmK NSPK. However, the affinities of BmK NSPK and BmKTX on Kv channels appeared to be similar.
It has been reported that universal Kv channels blocker as well as an array of specific Kv1 subfamily inhibitors augment the SCO activity in cortical neuronal cultures [18]. Similarly, suppression of Kv channels with Ba2+ has been shown to augment SCO activity in hypothalamic neurons [45]. SCO profile in spinal cord neuronal cultures is dependent on the action potential generation and is orchestrated by both neuronal excitatory and inhibitory inputs [46]. The release of Ca2+ from intracellular Ca2+ store through inositol 1, 4, 5-triphosphate (IP3) receptors, and ryanodine receptors was also involved in the occurrence of SCOs [18,32,47]. In the current study, we demonstrated that BmK NSPK increased the SCO frequency and amplitude and depolarized membrane with low apparent nanomolar affinity in SCN cultures, consistent with its high affinity on the outward potassium channels. Therefore, it is reasonable to conclude that BmK NSPK-enhanced SCO frequency and amplitude is originated from its inhibition of outward K+ currents in SCN cultures. BmK NSPK-enhanced SCO frequency and amplitude is likely stepped from its ability to produce membrane depolarization that enhances rhythmic glutamate release in the pre-synapse that triggers Ca2+ release through metabotropic glutamate receptor subtype 5 (mGluR5)-coupled phospholipase C/IP3 receptor pathways [18]. Slight membrane depolarization also can facilitate the action potential generation that may contribute to increased SCO frequency [48], as SCO was dependent on the action potential firing [46]. BmK NSPK-induced membrane depolarization is likely resulted from its inhibition of IA and ID currents. This is consistent with 4-aminopyridine, a transient Kv channel blocker, and tetraethylammonium, a delayed-rectifier Kv channel blocker, response on the membrane potential [49,50].
Neuronal activity regulates intracellular Ca2+ dynamics, and activity-dependent calcium signaling regulates neurite extension and dendritic branching [51]. In the current study, we demonstrated that BmK NSPK, a short-chain scorpion peptide, enhanced neurite outgrowth in a nonmonotonic manner. This nonmonotonic stimulation on the neurite outgrowth is consistent with activity-dependent neurite outgrowth by activation of VGSCs [52], activation of ryanodine receptors [32], or suppression of Kv1 channels [18]. We previously have reported a long-chain α-scorpion toxin (BmK NSP) that directly activated VGSCs by delaying inactivation of VGSCs [7]. BmK NSP also promoted neurite outgrowth that was suppressed by the inhibitors of L-type Ca2+ channels, N-methyl-D-aspartic acid receptors, and Na+-Ca2+ exchangers [7]. Although the currently reported short-chain scorpion toxin, BmK NSPK, also promoted the neurite outgrowth, the molecular mechanism was distinct from that of BmK NSP. BmK NSPK had little effect on VGSCs. The effect of BmK NSPK on neurite outgrowth likely resulted from its inhibition of Kv channels. Although both Bmk NSP and BmK NSPK affected the intracellular Ca2+ signaling, the phenotypes and molecular mechanisms were distinct. BmK NSP produced sustained intracellular Ca2+ elevation through L-type Ca2+ channels, N-methyl-D-aspartic acid receptors, and reverse mode of Na+–Ca2+ exchangers that were a consequence of activation of VGSCs [7,9]. However, BmK NSPK increased SCO amplitude and frequency. The effect of BmK NSPK on SCOs was similar to that of Kv1 and Kv3.1 channel blockers, which augmented SCO frequency and amplitude by enhancing Ca2+ release through mGluR5-coupled phospholipase C/IP3 receptor pathways [18].
An interesting finding was that BmK NSPK exposure stimulated NGF release in SCN cultures. NGF release can be augmented by depolarization, and depolarization augments Ca2+ signaling [53,54]. Therefore, it is likely that BmK NSPK-augmented release of NGF is triggered by the inhibition of outward potassium channels that leads to the membrane depolarization and augmented Ca2+ signaling. NGF is essential for proper development, patterning, and maintenance of nervous systems. NGF has been reported to enhance the neurite outgrowth in PC12 cells [38] and primary sensory neurons [39] through selective binding to TrkA receptors [55]. We demonstrated that GW 441756, a TrkA receptor inhibitor, eliminated BmK NSPK-induced neurite outgrowth, suggesting that the NGF/TrkA pathway was critical in the regulation of BmK NSPK-induced neurite outgrowth. Both NGF- and BmK NSPK-induced neurite outgrowth displayed a bell-shaped response that was also similar to the pattern of activity-dependent neurite outgrowth. Therefore, these data infer that activity-dependent neurite outgrowth is also likely through the NGF/TrkA pathway. Akt, the key molecules downstream of TrkA receptors, have been reported to be involved in survival, regeneration, and differentiation of neurons [40,56]. We demonstrated that BmK NSPK also stimulated the phosphorylation levels of Akt, further demonstrating the involvement of the NGF/TrkA signaling pathway in BmK NSPK-stimulated neurite outgrowth.
In summary, we purified a potent potassium channel blocker, designated to be BmK NSPK, from the scorpion Buthus martensii Karsch. We further demonstrated that BmK NSPK increased SCO frequency and amplitude, and stimulated neurite outgrowth in a nonmonotonic manner through NGF/TrkA receptor signaling pathway in SCNs. Potassium channels may represent molecular targets to modulate spinal cord regeneration and to develop the treatments of spinal cord injury.

4. Materials and Methods

4.1. Animal Care

All the animal protocols were approved by the Institutional Animal Care and Use Committee (#SYXK 2016-0011) of China Pharmaceutical University at 31 March, 2020. Efforts were made to reduce the number of experimental animals and to minimize animal suffering. C57BL/6 mice (18–22 g) were purchased from Qinglongshan Laboratory Animal Center (Nanjing, China). The animals were housed under standard environmental conditions (12/12 h light/dark cycle at 23 ± 2 °C). The chow and tap water were available ad libitum.

4.2. Materials

BmK venom was purchased from a domesticated scorpion farm (Kaifeng, China), where it was collected by electrical stimulation. Sephadex G-50 and CM-Sephadex C-50 were purchased from Pharmacia Fine Chemicals (Uppsala, Sweden). Acetonitrile (HPLC grade) was from Tedia (Cincinnati, OH, USA). Dialysis membrane (500 Da cut off) was a product of Minnesota Mining and Manufacturing (St. Paul, MN, USA). Trypsin, L-glutamine, fetal bovine serum, Neurobasal medium, Hoechst 33,342, and anti-MAP2 primary antibody were obtained from Life Technology (Grand Island, NY, USA). Primary antibodies against Akt, phosphorylated (p)-Akt, were obtained from Cell Signaling Technology (Danvers, MA, USA). Secondary antibodies and NewBlot Nitro Stripping Buffer were from LI-COR Biotechnology (Lincoln, NE, USA). Trifluoroacetic acid, cytosine arabinoside, poly-L-lysine, N-2-hydroxyethylpiperazine-N-2-ethane sulfonic acid (HEPES), GW 441756, and all inorganic salts were obtained from Sigma-Aldrich (St. Louis, MO, USA). Tetrodotoxin was purchased from Tocris Bioscience (Ellisville, MO, USA). The Ca2+-specific fluorescent dye Fluo-4/AM was obtained from AAT Bioquest (Sunnyvale, CA, USA). NGF ELISA kit was purchased from Kete Biological Technology Co., Ltd. (Nanjing, China).

4.3. BmK NSPK Purification

The scorpion venom was dissolved in ddH2O and loaded to a Sephadex G-50 column (35 × 700 mm) eluted with ddH2O. Four peaks (G-1 to G-4) were collected based on the absorbance at 280 nm. Fraction G-2 was loaded onto a pre-equilibrated CM-Sephadex C-50 cation ion-exchange column (26 × 500 mm) as described previously [21]. The fraction eluted with 0.5 M NaCl was dialyzed, lyophilized, and further separated in an Ultimate XB-C18 reverse-phase semipreparative column (9.6 × 250 mm, Welch Materials Inc., Shanghai, China) using an Agilent 1260 Infinity LC (Agilent Technologies, Santa Clara, CA, USA) high-performance liquid chromatography (HPLC) system. The column was eluted with different percentages of solvent A (0.1% Trifluoroacetic acid (TFA) in ddH2O) and solvent B (0.085% TFA, 70% acetonitrile in ddH2O) over time: from 0 to 5 min 19% B, 5–20 min, 28% B; 20–55 min, 48% B; 55–60 min, 19% B at a flow rate of 2 mL/min.

4.4. Mass Spectrometry

A Quattro micro triple quadrupole mass spectrometer (Waters, Milford, MA, USA) was used to determine the molecular weight of purified peptide by electrospray ionization (ESI) in a positive mode. The desolvation temperature was set at 300 °C, and the source temperature was 110 °C. The capillary voltage was 3.0 kV, with cone voltage at 30 V. Nitrogen was used as cone gas and desolvation gas. Peptide was dissolved in a mixture of acetonitrile: ddH2O at a ratio of 1:1 containing 0.1% formic acid.

4.5. Edman Degradation

The amino acid sequence of BmK NSPK was determined by Edman degradation on a Protein Sequencer, model PPSQ-33A (Shimadzu Co., Kyoto, Japan) as described previously [21].

4.6. Sequence Alignment and Molecular Modeling

The amino acid sequences of BmK NSPK and toxins from the Swiss-Prot database were compared and aligned using ClustalX software (v2.0, University College Dublin, Dublin, Ireland). Three-dimensional structure modeling of BmK NSPK was carried out by homology modeling using SWISS-MODEL workspace [57] using BmKTX (PDB code: 1BKT) [23] as a template.

4.7. Primary Culture of Spinal Cord Neurons (SCNs)

SCN cultures were performed as described previously [7]. The dissociated neurons were planted into poly-L-lysine-coated 35 mm Petri dishes, 96-well plates at densities of 2 × 103 cells/dish for patch clamp, 2.25 × 105 and 2 × 103 cells/well for Ca2+ imaging and neurite outgrowth experiments, respectively. Cells at 6–8 DIVs (days in vitro) were used to measure K+ and Na+ currents, membrane potential, or intracellular Ca2+ concentration ([Ca2+]i).

4.8. Intracellular Calcium Concentration Measurement

The intracellular Ca2+ concentration [Ca2+]i of SCNs was measured using FLIPRTetra® system (Molecular Devices, Sunnyvale, CA, USA) as described previously [32].

4.9. Whole-Cell Patch-Clamp Recording

Current-clamp recordings can provide useful information about the contribution of a channel to membrane potential. Membrane potentials, Na+ and K+ currents in SCNs (6–8 DIVs), were recorded using whole-cell patch clamp using an EPC-10 amplifier and PatchMaster software (HEKA, Pfalz, Germany). Pipettes were pulled from 1.5 mm capillary tubing using a P-1000 puller (Sutter Instrument, Novato, CA, USA). The pipette resistance was 2–4 MΩ.
For current-clamp recordings, to record changes in membrane potential, patch pipettes were filled with intracellular solution containing the following (in mM): KCl 140, MgCl2 5, CaCl2 2.5, EGTA 5, ATP 4, GTP 0.3, and HEPES 10 (pH adjusted to 7.3 with KOH). The external solution contained the following (in mM): NaCl 140, MgCl2 1, KCl 5, CaCl2 2, glucose 10, and HEPES 10 (pH adjusted to 7.3 with NaOH). The membrane potentials were recorded by a 0 pA input current with a duration of 1 s. For voltage-clamp recordings, to record potassium currents, patch pipettes were filled with an internal solution containing (in mM): KCl 140, CaCl2 1, MgCl2 2.5, HEPES 10, EGTA 11, and ATP 4, and pH was adjusted to 7.2 with KOH. Cells were bathed in an external solution containing the following (in mM): choline chloride 150, KCl 5, MgCl2 1, HEPES 10, D-glucose 10, and NMDG 2, and pH was adjusted to 7.4 with KOH. To record sodium currents, patch pipettes were filled with an internal solution containing the following (in mM): CsF 135, HEPES 5, and NaCl 10, and pH was adjusted to 7.2 with CsOH. Cells were bathed in external solution containing the following (in amM): NaCl 30, MgCl2 1, CaCl2 1.8, CsCl 5, D-glucose 25, KCl 5, HEPES 5, TEACl 90, and KCl 5, and pH was adjusted to 7.4 with NaOH. Capacitance and series resistance were compensated using computer-controlled circuitry of the amplifier. The outward potassium currents (IK), which contain both transient (IA) and sustained delayed-rectifier (ID) components, were elicited by a series of depolarizing pulses from −110 mV to the potentials ranged from −60 to +80 mV in a 10 mV increment. To record the ID currents, voltages were stepped to the potentials ranged from −60 to +80 mV in a 10 mV increment from a 200 ms pre-depolarization potential of −40 mV that inactivated IA currents. IA currents were obtained by subtracting ID currents from IK currents. Na+ currents were elicited by depolarization steps from a holding potential of −100 mV to +45 mV in a 5 mV increment. Data were collected and analyzed using PatchMaster (HEKA Electronics, Pfalz, Germany) and SigmaPlot (version 10.3, Sigma-Aldrich). Concentration–response curves were fitted using the Hill equation: Inor= C + A/[1 + ([BmK NSPK]/EC50)p] [9], where [BmK NSPK] is the BmK NSPK concentration, C is the offset, the A values were always held to the values obtained under control conditions, Inor is the normalized peak current (Inormalize), EC50 is the half-maximal effective concentration, and p is the Hill slope [58].

4.10. Immunocytochemistry

Immunocytochemistry was performed as described previously [7]. After fixation, permeabilization, and blocking, neurons were incubated with primary antibody against MAP2 (1:1000) overnight at 4 °C and Alexa Fluor 488-conjugated goat anti-rabbit secondary antibody (1:1000) for 1 h at room temperature (RT), respectively. Hoechst 33,342 (1.6 μg/mL) was added into each well and incubated for 20 min to stain the nuclei. The images were captured by an eclipse inverted fluorescence microscope (Nikon, Tokyo, Japan). Neurites were manually tracked using ImageJ software (FIJI, version 1.51 g, NIH, Bethesda, MD, USA). Only the neurons with total neurite length ≥50 μm were used for quantification. The experiment was performed double blindly.

4.11. Enzyme-Linked Immunosorbent Assay (ELISA)

The NGF levels in the culture medium were determined by enzyme-linked immunosorbent assay (ELISA) kits according to the manufacturer’s instructions.

4.12. Western Blot

Equal amounts (30 μg) of cell lysates were loaded onto a 10% SDS-PAGE gel and transferred to a nitrocellulose membrane by electroblotting. After blocking, the blots were incubated with primary antibodies against p-Akt (1:1000) overnight at 4 °C and then incubated with the IRDye (680 RD or 800 CW)-labeled secondary antibodies (1:10,000) for 1 h at RT. The membranes were scanned and densitometry was quantified using LI-COR Odyssey Infrared Imaging System and its application software (version 2.1, LI-COR Biotechnology). The membranes were stripped with stripping buffer (LI-COR Biotechnology) and reblotted for analysis of the expression of Akt. Beta-tubulin (1:10,000) was used as a loading control.

4.13. Data Analysis

All data were presented as mean ± SEM. Graphing and data analysis were performed using GraphPad Prism software (Version 6.0, San Diego, CA, USA). Concentration–response curves were fitted by a nonlinear logistic equation. The IC50 values and 95% confidence intervals (CI) were determined by nonlinear regression using GraphPad Prism software. Statistical significance between different groups was calculated using an ANOVA and, where appropriate, a Dunnett′s multiple comparison test. A p-value below 0.05 was considered statistically significant.

Author Contributions

Conceptualization, Z.C., X.Z. and Y.W.; methodology, X.Z.; software, C.X.; validation, J.H.; formal analysis, S.L.; investigation, X.Z. and F.Z.; resources, Z.C.; data curation, X.Z. and F.Z.; writing—original draft preparation, F.Z. and X.Z.; writing—review and editing, Z.C.; visualization, Q.T.; supervision, Z.C.; project administration, Z.C.; funding acquisition, Z.C. and X.Z. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the National Natural Science Foundation of China (81903826, 81972960, 21777192, 81473539); National Science and Technology Major Projects for Major New Drugs Innovation and Development (2018ZX09101003-004-002); and China Postdoctoral Science Foundation (2018M630645, 2018M642371).

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Institutional Animal Care and Use Committee (#SYXK 2016-0011) of China Pharmaceutical University at 31 March 2020.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data sharing not applicable. No new data were created or analyzed in this study. Data sharing is not applicable to this article.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Lavon, O.; Bentur, Y. Poison exposures in young Israeli military personnel: A National Poison Center Data analysis. Clin. Toxicol. 2017, 55, 322–325. [Google Scholar] [CrossRef]
  2. Kang, A.M.; Brooks, D.E. Geographic distribution of scorpion exposures in the United States, 2010–2015. Am. J. Public Health 2017, 107, 1958–1963. [Google Scholar] [CrossRef] [PubMed]
  3. Zhang, F.; Wu, Y.; Zou, X.; Tang, Q.; Zhao, F.; Cao, Z. BmK AEP, an anti-epileptic peptide distinctly affects the gating of brain subtypes of voltage-gated sodium channels. Int. J. Mol. Sci. 2019, 20, 729. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Wang, Z.; Wang, W.; Shao, Z.; Gao, B.; Li, J.; Ma, J.; Li, J.; Che, H.; Zhang, W. Eukaryotic expression and purification of anti-epilepsy peptide of Buthus martensii Karsch and its protein interactions. Mol. Cell. Biochem. 2009, 330, 97. [Google Scholar] [CrossRef] [PubMed]
  5. Zhou, X. The biochemical research on scorpion venoms and their application in therapy. Progr. Biochem. Biophys. 1984, 56, 20–29. [Google Scholar] [CrossRef]
  6. Mao, Q.; Ruan, J.; Cai, X.; Lu, W.; Ye, J.; Yang, J.; Yang, Y.; Sun, X.; Cao, J.; Cao, P. Antinociceptive effects of analgesic-antitumor peptide (AGAP), a neurotoxin from the scorpion Buthus martensii Karsch, on formalin-induced inflammatory pain through a mitogen-activated protein kinases–dependent mechanism in mice. PLoS ONE 2013, 8, e78239. [Google Scholar] [CrossRef] [PubMed]
  7. Zou, X.; Wang, Y.; Yu, Y.; He, J.; Zhao, F.; Xi, C.; Zhang, C.; Cao, Z. BmK NSP, a new sodium channel activator from Buthus martensii Karsch, promotes neurite outgrowth in primary cultured spinal cord neurons. Toxicon 2020. [Google Scholar] [CrossRef] [PubMed]
  8. Luna-Ramírez, K.; Bartok, A.; Restano-Cassulini, R.; Quintero-Hernández, V.; Coronas, F.I.; Christensen, J.; Wright, C.E.; Panyi, G.; Possani, L.D. Structure, molecular modeling, and function of the novel potassium channel blocker urotoxin isolated from the venom of the Australian scorpion Urodacus yaschenkoi. Mol. Pharmacol. 2014, 86, 28–41. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  9. He, Y.; Zou, X.; Li, X.; Chen, J.; Jin, L.; Zhang, F.; Yu, B.; Cao, Z. Activation of sodium channels by α-scorpion toxin, BmK NT1, produced neurotoxicity in cerebellar granule cells: An association with intracellular Ca2+ overloading. Arch. Toxicol. 2017, 91, 935–948. [Google Scholar] [CrossRef] [PubMed]
  10. Chuang, R.S.; Jaffe, H.; Cribbs, L.; Perez-Reyes, E.; Swartz, K.J. Inhibition of T-type voltage-gated calcium channels by a new scorpion toxin. Nat. Neurosci. 1998, 1, 668–674. [Google Scholar] [CrossRef]
  11. Dardevet, L.; Rani, D.; Aziz, T.A.E.; Bazin, I.; Sabatier, J.-M.; Fadl, M.; Brambilla, E.; De Waard, M. Chlorotoxin: A helpful natural scorpion peptide to diagnose glioma and fight tumor invasion. Toxins 2015, 7, 1079–1101. [Google Scholar] [CrossRef] [PubMed]
  12. Vargas-Jaimes, L.; Xiao, L.; Zhang, J.; Possani, L.D.; Valdivia, H.H.; Quintero-Hernández, V. Recombinant expression of Intrepicalcin from the scorpion Vaejovis intrepidus and its effect on skeletal ryanodine receptors. Biochim. Biophys. Acta (BBA) Gen. Subj. 2017, 1861, 936–946. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Chen, Z.; Hu, Y.; Wang, B.; Cao, Z.; Li, W.; Wu, Y. A single conserved basic residue in the potassium channel filter region controls KCNQ1 insensitivity toward scorpion toxins. Biochem. Biophys. Rep. 2015, 3, 62–67. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Dueñas-Cuellar, R.A.; Santana, C.J.C.; Magalhães, A.C.M.; Pires, O.R.; Fontes, W.; Castro, M.S. Scorpion Toxins and Ion Channels: Potential Applications in Cancer Therapy. Toxins 2020, 12, 326. [Google Scholar] [CrossRef] [PubMed]
  15. Cornet, B.; Bonmatin, J.-M.; Hetru, C.; Hoffmann, J.A.; Ptak, M.; Vovelle, F. Refined three-dimensional solution structure of insect defensin A. Structure 1995, 3, 435–448. [Google Scholar] [CrossRef] [Green Version]
  16. Van Ooyen, A.; Van Pelt, J. Activity-dependent neurite outgrowth and neural network development. In Progress in Brain Research; Elsevier: Amsterdam, The Netherlands, 1994; Volume 102, pp. 245–259. [Google Scholar]
  17. Zheng, J.Q.; Poo, M.-M. Calcium signaling in neuronal motility. Annu. Rev. Cell Dev. Biol. 2007, 23. [Google Scholar] [CrossRef] [Green Version]
  18. Cao, Z.; Cui, Y.; Busse, E.; Mehrotra, S.; Rainier, J.D.; Murray, T.F. Gambierol inhibition of voltage-gated potassium channels augments spontaneous Ca2+ oscillations in cerebrocortical neurons. J. Pharmacol. Exp. Ther. 2014, 350, 615–623. [Google Scholar] [CrossRef] [Green Version]
  19. George, J.; Baden, D.G.; Gerwick, W.H.; Murray, T.F. Bidirectional influence of sodium channel activation on NMDA receptor–dependent cerebrocortical neuron structural plasticity. Proc. Natl. Acad. Sci. USA 2012, 109, 19840–19845. [Google Scholar] [CrossRef] [Green Version]
  20. Wang, T.; Wang, S.-W.; Zhang, Y.; Wu, X.-F.; Peng, Y.; Cao, Z.; Ge, B.-Y.; Wang, X.; Wu, Q.; Lin, J.-T. Scorpion venom heat-resistant peptide (SVHRP) enhances neurogenesis and neurite outgrowth of immature neurons in adult mice by up-regulating brain-derived neurotrophic factor (BDNF). PLoS ONE 2014, 9, e109977. [Google Scholar] [CrossRef]
  21. Zou, X.; Wu, Y.; Chen, J.; Zhao, F.; Zhang, F.; Yu, B.; Cao, Z. Activation of sodium channel by a novel α-scorpion toxin, BmK NT2, stimulates ERK1/2 and CERB phosphorylation through a Ca2+ dependent pathway in neocortical neurons. Int. J. Biol. Macromol. 2017, 104, 70–77. [Google Scholar] [CrossRef]
  22. Calabrese, E.J. Enhancing and regulating neurite outgrowth. Crit. Rev. Toxicol. 2008, 38, 391–418. [Google Scholar] [CrossRef]
  23. Renisio, J.G.; Romi-Lebrun, R.; Blanc, E.; Bornet, O.; Nakajima, T.; Darbon, H. Solution structure of BmKTX, a K+ blocker toxin from the Chinese scorpion Buthus Martensi. Proteins Struct. Funct. Bioinform. 2000, 38, 70–78. [Google Scholar] [CrossRef]
  24. De La Vega, R.C.R.G.; Possani, L.D. Current views on scorpion toxins specific for K+-channels. Toxicon 2004, 43, 865–875. [Google Scholar] [CrossRef] [PubMed]
  25. Gao, B.; Peigneur, S.; Tytgat, J.; Zhu, S. A potent potassium channel blocker from Mesobuthus eupeus scorpion venom. Biochimie 2010, 92, 1847–1853. [Google Scholar] [CrossRef] [PubMed]
  26. Gigolaev, A.M.; Kuzmenkov, A.I.; Peigneur, S.; Tabakmakher, V.M.; Pinheiro-Junior, E.L.; Chugunov, A.O.; Efremov, R.G.; Tytgat, J.; Vassilevski, A.A. Tuning Scorpion Toxin Selectivity: Switching From KV1. 1 to KV1. 3. Front. Pharmacol. 2020, 11, 1010. [Google Scholar] [CrossRef] [PubMed]
  27. Norton, R.S.; Chandy, K.G. Venom-derived peptide inhibitors of voltage-gated potassium channels. Neuropharmacology 2017, 127, 124–138. [Google Scholar] [CrossRef] [PubMed]
  28. Wang, X.-S.; Gruenstein, E.I. Mechanism of synchronized Ca2+ oscillations in cortical neurons. Brain Res. 1997, 767, 239–249. [Google Scholar] [CrossRef]
  29. Czarnecki, A.; Magloire, V.; Streit, J. Local oscillations of spiking activity in organotypic spinal cord slice cultures. Eur. J. Neurosci. 2008, 27, 2076–2088. [Google Scholar] [CrossRef] [PubMed]
  30. Cao, Z.; Hammock, B.D.; McCoy, M.; Rogawski, M.A.; Lein, P.J.; Pessah, I.N. Tetramethylenedisulfotetramine alters Ca2+ dynamics in cultured hippocampal neurons: Mitigation by NMDA receptor blockade and GABAA receptor-positive modulation. Toxicol. Sci. 2012, 130, 362–372. [Google Scholar] [CrossRef] [Green Version]
  31. Zhang, C.-L.; Huang, Q.-L.; Chen, J.; Zhang, W.-J.; Jin, H.-X.; Wang, H.-B.; Naman, C.B.; Cao, Z.-Y. Phthalideisoquinoline Hemiacetal Alkaloids from Corydalis decumbens That Inhibit Spontaneous Calcium Oscillations, Including Alkyl Derivatives of (+)-Egenine That Are Strikingly Levorotatory. J. Nat. Prod. 2019, 82, 2713–2720. [Google Scholar] [CrossRef]
  32. Zheng, J.; Yu, Y.; Feng, W.; Li, J.; Liu, J.; Zhang, C.; Dong, Y.; Pessah, I.N.; Cao, Z. Influence of nanomolar deltamethrin on the hallmarks of primary cultured cortical neuronal network and the role of ryanodine receptors. Environ. Health Perspect. 2019, 127, 067003. [Google Scholar] [CrossRef] [PubMed]
  33. Cao, Z.; Cui, Y.; Nguyen, H.M.; Jenkins, D.P.; Wulff, H.; Pessah, I.N. Nanomolar bifenthrin alters synchronous Ca2+ oscillations and cortical neuron development independent of sodium channel activity. Mol. Pharmacol. 2014, 85, 630–639. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Cao, Z.; Shen, W.Q.; Pan, Y.P.; Xiao, X.; Liu, X.M.; Wang, X.L.; Liang, X.T.; Yu, D.Q. Purification, characterization of two peptides from Buthus martensi Karch. Chem. Biol. Drug Des. 2010, 62, 252–259. [Google Scholar] [CrossRef] [PubMed]
  35. Shibata, R.; Nakahira, K.; Shibasaki, K.; Wakazono, Y.; Imoto, K.; Ikenaka, K. A-type K+ current mediated by the Kv4 channel regulates the generation of action potential in developing cerebellar granule cells. J. Neurosci. 2000, 20, 4145–4155. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Dodson, P.D.; Forsythe, I.D. Presynaptic K+ channels: Electrifying regulators of synaptic terminal excitability. Trends Neurosci. 2004, 27, 210–217. [Google Scholar] [CrossRef]
  37. Breton, J.D.; Poisbeau, P.; Darbon, P. Antinociceptive action of oxytocin involves inhibition of potassium channel currents in lamina II neurons of the rat spinal cord. Mol. Pain 2009, 5, 1744–8069. [Google Scholar] [CrossRef] [Green Version]
  38. Howe, C.L. Depolarization of PC12 cells induces neurite outgrowth and enhances nerve growth factor-induced neurite outgrowth in rats. Neurosci. Lett. 2003, 351, 41–45. [Google Scholar] [CrossRef]
  39. Castillo, X.; Melo, Z.; Varela-Echavarría, A.; Tamariz, E.; Aroña, R.M.; Arnold, E.; Clapp, C.; de la Escalera, G.M. Vasoinhibin suppresses the neurotrophic effects of VEGF and NGF in newborn rat primary sensory neurons. Neuroendocrinology 2018, 106, 221–233. [Google Scholar] [CrossRef]
  40. Song, E.-J.; Yoo, Y.-S. Nerve growth factor-induced neurite outgrowth is potentiated by stabilization of TrkA receptors. BMB Rep. 2011, 44, 182–186. [Google Scholar] [CrossRef] [Green Version]
  41. Xie, Y.; Tisi, M.A.; Yeo, T.T.; Longo, F.M. Nerve growth factor (NGF) loop 4 dimeric mimetics activate ERK and AKT and promote NGF-like neurotrophic effects. J. Biol. Chem. 2000, 275, 29868–29874. [Google Scholar] [CrossRef] [Green Version]
  42. Bergeron, Z.L.; Bingham, J.-P. Scorpion toxins specific for potassium (K+) channels: A historical overview of peptide bioengineering. Toxins 2012, 4, 1082–1119. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Ortiz, E.; Possani, L.D. Scorpion toxins to unravel the conundrum of ion channel structure and functioning. Toxicon 2018, 150, 17–27. [Google Scholar] [CrossRef] [PubMed]
  44. Romi-Lebrun, R.; Lebrun, B.; Martin-Eauclaire, M.-F.; Ishiguro, M.; Escoubas, P.; Wu, F.Q.; Hisada, M.; Pongs, O.; Nakajima, T. Purification, characterization, and synthesis of three novel toxins from the Chinese scorpion Buthus martensi, which act on K+ channels. Biochemistry 1997, 36, 13473–13482. [Google Scholar] [CrossRef] [PubMed]
  45. Costantin, J.L.; Charles, A.C. Modulation of Ca2+ Signaling by K+ Channels in a Hypothalamic Neuronal Cell Line (GT1–1). J. Neurophysiol. 2001, 85, 295–304. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Kelamangalath, L.; Dravid, S.M.; George, J.; Aldrich, J.V.; Murray, T.F. κ-Opioid receptor inhibition of calcium oscillations in spinal cord neurons. Mol. Pharmacol. 2011, 79, 1061–1071. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  47. Dravid, S.M.; Murray, T.F. Spontaneous synchronized calcium oscillations in neocortical neurons in the presence of physiological [Mg2+]: Involvement of AMPA/kainate and metabotropic glutamate receptors. Brain Res. 2004, 1006, 8–17. [Google Scholar] [CrossRef] [PubMed]
  48. Wu, Z.; Yang, Q.; Crook, R.J.; O’Neil, R.G.; Walters, E.T. TRPV1 channels make major contributions to behavioral hypersensitivity and spontaneous activity in nociceptors after spinal cord injury. PAIN 2013, 154, 2130–2141. [Google Scholar] [CrossRef] [PubMed]
  49. McAlexander, M.A.; Undem, B.J. Potassium channel blockade induces action potential generation in guinea-pig airway vagal afferent neurones. J. Auton. Nerv. Syst. 2000, 78, 158–164. [Google Scholar] [CrossRef]
  50. Wilson, J.R.; Duncan, N.A.; Giles, W.R.; Clark, R.B. A voltage-dependent K+ current contributes to membrane potential of acutely isolated canine articular chondrocytes. J. Physiol. 2004, 557, 93–104. [Google Scholar] [CrossRef]
  51. Konur, S.; Ghosh, A. Calcium signaling and the control of dendritic development. Neuron 2005, 46, 401–405. [Google Scholar] [CrossRef] [Green Version]
  52. George, J.; Dravid, S.M.; Prakash, A.; Xie, J.; Peterson, J.; Jabba, S.V.; Baden, D.G.; Murray, T.F. Sodium channel activation augments NMDA receptor function and promotes neurite outgrowth in immature cerebrocortical neurons. J. Neurosci. 2009, 29, 3288–3301. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  53. Reber, B.; Porzig, H.; Becker, C.; Reuter, H. Depolarization-induced changes of free intracellular Ca2+ concentration and of [3H] dopamine release in undifferentiated and differentiated PC12 cells. Neurochem. Int. 1990, 17, 197–203. [Google Scholar] [CrossRef]
  54. Wu, Y.; Krüttgen, A.; Möller, J.; Shine, D.; Chan, J.; Shooter, E.; Cosgaya, J. Nerve growth factor, brain-derived neurotrophic factor, and neurotrophin-3 are sorted to dense-core vesicles and released via the regulated pathway in primary rat cortical neurons. J. Neurosci. Res. 2004, 75, 825–834. [Google Scholar] [CrossRef] [PubMed]
  55. Zhang, Y.; Wang, Y.-G.; Zhang, Q.; Liu, X.-J.; Liu, X.; Jiao, L.; Zhu, W.; Zhang, Z.-H.; Zhao, X.-L.; He, C. Interaction of Mint2 with TrkA is involved in regulation of nerve growth factor-induced neurite outgrowth. J. Biol. Chem. 2009, 284, 12469–12479. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  56. Okada, K.; Tanaka, H.; Temporin, K.; Okamoto, M.; Kuroda, Y.; Moritomo, H.; Murase, T.; Yoshikawa, H. Akt/mammalian target of rapamycin signaling pathway regulates neurite outgrowth in cerebellar granule neurons stimulated by methylcobalamin. Neurosci. Lett. 2011, 495, 201–204. [Google Scholar] [CrossRef] [PubMed]
  57. Bordoli, L.; Kiefer, F.; Arnold, K.; Benkert, P.; Battey, J.; Schwede, T. Protein structure homology modeling using SWISS-MODEL workspace. Nat. Protoc. 2009, 4, 1. [Google Scholar] [CrossRef] [PubMed]
  58. Gadagkar, S.R.; Call, G.B. Computational tools for fitting the Hill equation to dose–response curves. J. Pharmacol. Toxicol. Methods 2015, 71, 68–76. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Figure 1. HPLC purification of Buthus martensii Karsch neurite-stimulating peptide targeting Kv channels (BmK NSPK). (A) Representative RP-HPLC chromatogram of the fraction eluted with 0.5 M NaCl in an CM-Sephadex C-50 cation ion-exchange column. The column was eluted with different percentages of solvent A (0.1% Trifluoroacetic acid (TFA) in ddH2O) and solvent B (0.085% TFA, 70% acetonitrile in ddH2O): from 0 to 5 min, 19% B, 5–20 min, 28% B; 20–55 min, 48% B; 55–60 min, 19% B at a flow rate of 2 mL/min. The arrowhead indicates the peak of BmK NSPK. (B) Representative RP-HPLC chromatogram of purified BmK NSPK eluted with gradient of acetonitrile: solvent A (0.1% TFA in ddH2O) and solvent B (0.085% TFA, 70% acetonitrile in ddH2O): from 0 to 10 min, 99.5% B; 10–70 min, 58% B; 70–75 min, 99.5% B at a flow rate of 1 mL/min. A single peak (indicated by arrowhead) was observed, suggesting that BmK NSPK is of high purity. (C) ESI-MS of BmK NSPK. The multiple ion charges of 1321.7, 991.6, and 793.5 m/z corresponded to [M+3H]3+, [M+4H]4+, and [M+5H]5+, respectively.
Figure 1. HPLC purification of Buthus martensii Karsch neurite-stimulating peptide targeting Kv channels (BmK NSPK). (A) Representative RP-HPLC chromatogram of the fraction eluted with 0.5 M NaCl in an CM-Sephadex C-50 cation ion-exchange column. The column was eluted with different percentages of solvent A (0.1% Trifluoroacetic acid (TFA) in ddH2O) and solvent B (0.085% TFA, 70% acetonitrile in ddH2O): from 0 to 5 min, 19% B, 5–20 min, 28% B; 20–55 min, 48% B; 55–60 min, 19% B at a flow rate of 2 mL/min. The arrowhead indicates the peak of BmK NSPK. (B) Representative RP-HPLC chromatogram of purified BmK NSPK eluted with gradient of acetonitrile: solvent A (0.1% TFA in ddH2O) and solvent B (0.085% TFA, 70% acetonitrile in ddH2O): from 0 to 10 min, 99.5% B; 10–70 min, 58% B; 70–75 min, 99.5% B at a flow rate of 1 mL/min. A single peak (indicated by arrowhead) was observed, suggesting that BmK NSPK is of high purity. (C) ESI-MS of BmK NSPK. The multiple ion charges of 1321.7, 991.6, and 793.5 m/z corresponded to [M+3H]3+, [M+4H]4+, and [M+5H]5+, respectively.
Toxins 13 00033 g001
Figure 2. Homology of BmK NSPK with other scorpion toxins. (A) Multiple alignment analysis using ClustalX software showed that BmK NSPK displays over 70% similarity with reported voltage-gated potassium (Kv) channel blockers. The asterisk, dot, and colon above the sequences represent the concordance of amino acid residues in the same position: the asterisk means 100% similarity, the dot means semiconservative mutation, and the colon means conservative mutation. (B) Three-dimensional (3D) structure modeling of BmK NSPK using Buthus martensii Kaliotoxin (BmKTX, PDB code: 1BKT) as a temperate. Yellow sticks indicate the disulfide bridges.
Figure 2. Homology of BmK NSPK with other scorpion toxins. (A) Multiple alignment analysis using ClustalX software showed that BmK NSPK displays over 70% similarity with reported voltage-gated potassium (Kv) channel blockers. The asterisk, dot, and colon above the sequences represent the concordance of amino acid residues in the same position: the asterisk means 100% similarity, the dot means semiconservative mutation, and the colon means conservative mutation. (B) Three-dimensional (3D) structure modeling of BmK NSPK using Buthus martensii Kaliotoxin (BmKTX, PDB code: 1BKT) as a temperate. Yellow sticks indicate the disulfide bridges.
Toxins 13 00033 g002
Figure 3. BmK NSPK-augmented spontaneous Ca2+ oscillations and depolarized membrane in spinal cord neurons (SCNs). (A) Representative traces showing BmK NSPK effect on spontaneous calcium oscillation (SCOs) in SCNs. (B) Concentration–response curve of BmK NSPK-altered SCO frequency. (C) Concentration–response curve of BmK NSPK-altered SCO amplitude. N = 4 wells. (D) Representative traces showing BmK NSPK effect in membrane potential (0 pA input) before and after addition of BmK NSPK in SCNs. The black arrowheads indicated the addition of vehicle control. The red, green, blue, and purple arrowheads indicated the additions of different concentrations of BmK NSPK. (E) BmK NSPK depolarizes SCNs membrane. *, p < 0.05, **, p < 0.01, vs. Vehicle (Veh).
Figure 3. BmK NSPK-augmented spontaneous Ca2+ oscillations and depolarized membrane in spinal cord neurons (SCNs). (A) Representative traces showing BmK NSPK effect on spontaneous calcium oscillation (SCOs) in SCNs. (B) Concentration–response curve of BmK NSPK-altered SCO frequency. (C) Concentration–response curve of BmK NSPK-altered SCO amplitude. N = 4 wells. (D) Representative traces showing BmK NSPK effect in membrane potential (0 pA input) before and after addition of BmK NSPK in SCNs. The black arrowheads indicated the addition of vehicle control. The red, green, blue, and purple arrowheads indicated the additions of different concentrations of BmK NSPK. (E) BmK NSPK depolarizes SCNs membrane. *, p < 0.05, **, p < 0.01, vs. Vehicle (Veh).
Toxins 13 00033 g003
Figure 4. BmK NSPK directly inhibited outward K+ currents in SCNs and had no effect on the Na+ currents. (A) Representative traces for BmK NSPK inhibition of outward K+ (IK) currents (transient components (IA) + sustained delayed-rectifier components (ID)) elicited by depolarizing potentials ranging from −60 to +80 mV (10 mV increase) from a holding potential of −110 mV. (B) Current–voltage (I-V) curve of 300 nM BmK NSPK inhibition of IK currents. (C) Representative traces of IK currents elicited by a step depolarization from a holding potential of −110 mV to +70 mV in the absence and presence of different concentrations of BmK NSPK. (D) Representative traces for BmK NSPK inhibition of ID currents elicited by stepping to the potentials ranging from −60 to +80 mV (10 mV increment) from a pre-depolarized potential of −40 mV for 200 ms. (E) Current–voltage (I-V) curve of 300 nM BmK NSPK inhibition of ID currents. (F) Representative traces of ID currents elicited by a step depolarization from a pre-depolarized potential of −40 mV to +70 mV in the absence and presence of different concentrations of BmK NSPK. (G) Representative traces for BmK NSPK inhibition of IA currents. IA currents were obtained by subtracting ID currents (D) from IK currents (A). (H) Current–voltage (I-V) curve of 300 nM BmK NSPK inhibition of IA currents. (I) Representative traces of IA currents in the absence and presence of different concentrations of BmK NSPK. (J) Concentration–response curves of BmK NSPK inhibition of IK, ID, and IA currents. (K) Representative traces of Na+ currents elicited by depolarizations from −100 mV to +45 mV in the absence and presence of BmK NSPK (1000 nM) or tetrodotoxin (TTX, 3 nM). TTX but not BmK NSPK inhibited Na+ currents in cultured SCNs. N = 4–5 neurons.
Figure 4. BmK NSPK directly inhibited outward K+ currents in SCNs and had no effect on the Na+ currents. (A) Representative traces for BmK NSPK inhibition of outward K+ (IK) currents (transient components (IA) + sustained delayed-rectifier components (ID)) elicited by depolarizing potentials ranging from −60 to +80 mV (10 mV increase) from a holding potential of −110 mV. (B) Current–voltage (I-V) curve of 300 nM BmK NSPK inhibition of IK currents. (C) Representative traces of IK currents elicited by a step depolarization from a holding potential of −110 mV to +70 mV in the absence and presence of different concentrations of BmK NSPK. (D) Representative traces for BmK NSPK inhibition of ID currents elicited by stepping to the potentials ranging from −60 to +80 mV (10 mV increment) from a pre-depolarized potential of −40 mV for 200 ms. (E) Current–voltage (I-V) curve of 300 nM BmK NSPK inhibition of ID currents. (F) Representative traces of ID currents elicited by a step depolarization from a pre-depolarized potential of −40 mV to +70 mV in the absence and presence of different concentrations of BmK NSPK. (G) Representative traces for BmK NSPK inhibition of IA currents. IA currents were obtained by subtracting ID currents (D) from IK currents (A). (H) Current–voltage (I-V) curve of 300 nM BmK NSPK inhibition of IA currents. (I) Representative traces of IA currents in the absence and presence of different concentrations of BmK NSPK. (J) Concentration–response curves of BmK NSPK inhibition of IK, ID, and IA currents. (K) Representative traces of Na+ currents elicited by depolarizations from −100 mV to +45 mV in the absence and presence of BmK NSPK (1000 nM) or tetrodotoxin (TTX, 3 nM). TTX but not BmK NSPK inhibited Na+ currents in cultured SCNs. N = 4–5 neurons.
Toxins 13 00033 g004
Figure 5. BmK NSPK enhanced neurite outgrowth. (A) Representative immunofluorescence images of SCNs stained with microtubule-associated protein-2 (MAP2) and Hoechst 33,342. Scale bar: 10 μm. (B) Quantification of BmK NSPK response on neurite extension. N means the number of neurons. **, p < 0.01, vs. Veh.
Figure 5. BmK NSPK enhanced neurite outgrowth. (A) Representative immunofluorescence images of SCNs stained with microtubule-associated protein-2 (MAP2) and Hoechst 33,342. Scale bar: 10 μm. (B) Quantification of BmK NSPK response on neurite extension. N means the number of neurons. **, p < 0.01, vs. Veh.
Toxins 13 00033 g005
Figure 6. BmK NSPK increased nerve growth factor (NGF) release and enhanced neurite extension via tyrosine kinases A (TrkA) receptor. (A) 10 nM BmK NSPK increased NGF release. *, p < 0.05, BmK NSPK vs. Veh (n = 4). (B) Representative immunofluorescent pictures of SCNs stained with MAP2 and Hoechst 33,342 after Veh or BmK NSPK (10 nM), BmK NSPK + GW 441756 (GW, 1 µM) exposure for 48 h. Scale bar: 10 μm. (C) Quantification of GW effect on BmK NSPK-induced neurite extension. N means the number of neurons. **, p < 0.01, vs. Veh; ##, p < 0.01, vs. BmK NSPK.
Figure 6. BmK NSPK increased nerve growth factor (NGF) release and enhanced neurite extension via tyrosine kinases A (TrkA) receptor. (A) 10 nM BmK NSPK increased NGF release. *, p < 0.05, BmK NSPK vs. Veh (n = 4). (B) Representative immunofluorescent pictures of SCNs stained with MAP2 and Hoechst 33,342 after Veh or BmK NSPK (10 nM), BmK NSPK + GW 441756 (GW, 1 µM) exposure for 48 h. Scale bar: 10 μm. (C) Quantification of GW effect on BmK NSPK-induced neurite extension. N means the number of neurons. **, p < 0.01, vs. Veh; ##, p < 0.01, vs. BmK NSPK.
Toxins 13 00033 g006
Figure 7. BmK NSPK phosphorylated protein kinase B (Akt) in primary SCNs. Representative western blots (A) and quantification (B) for BmK NSPK (30 nM)-stimulated phosphorylation of Akt. Each point represents mean ± SEM (n = 4). **, p < 0.01, vs. Veh.
Figure 7. BmK NSPK phosphorylated protein kinase B (Akt) in primary SCNs. Representative western blots (A) and quantification (B) for BmK NSPK (30 nM)-stimulated phosphorylation of Akt. Each point represents mean ± SEM (n = 4). **, p < 0.01, vs. Veh.
Toxins 13 00033 g007
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Zhao, F.; Zou, X.; Li, S.; He, J.; Xi, C.; Tang, Q.; Wang, Y.; Cao, Z. BmK NSPK, a Potent Potassium Channel Inhibitor from Scorpion Buthus martensii Karsch, Promotes Neurite Outgrowth via NGF/TrkA Signaling Pathway. Toxins 2021, 13, 33. https://doi.org/10.3390/toxins13010033

AMA Style

Zhao F, Zou X, Li S, He J, Xi C, Tang Q, Wang Y, Cao Z. BmK NSPK, a Potent Potassium Channel Inhibitor from Scorpion Buthus martensii Karsch, Promotes Neurite Outgrowth via NGF/TrkA Signaling Pathway. Toxins. 2021; 13(1):33. https://doi.org/10.3390/toxins13010033

Chicago/Turabian Style

Zhao, Fang, Xiaohan Zou, Shaoheng Li, Jing He, Chuchu Xi, Qinglian Tang, Yujing Wang, and Zhengyu Cao. 2021. "BmK NSPK, a Potent Potassium Channel Inhibitor from Scorpion Buthus martensii Karsch, Promotes Neurite Outgrowth via NGF/TrkA Signaling Pathway" Toxins 13, no. 1: 33. https://doi.org/10.3390/toxins13010033

APA Style

Zhao, F., Zou, X., Li, S., He, J., Xi, C., Tang, Q., Wang, Y., & Cao, Z. (2021). BmK NSPK, a Potent Potassium Channel Inhibitor from Scorpion Buthus martensii Karsch, Promotes Neurite Outgrowth via NGF/TrkA Signaling Pathway. Toxins, 13(1), 33. https://doi.org/10.3390/toxins13010033

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop